About three in 10 adults report not taking their medicines as prescribed at some point in the past year because of the cost, according to a survey by KFF.
Affordability of prescription drugs is a key issue for Americans, according to a survey by KFF. This is especially true for those who are taking four or more prescriptions; 37% of these respondents say they have difficulty affording their prescriptions, compared with 18% who currently take three or fewer prescription medications. Those with household incomes of than the $40,000 are more likely to report difficulty affording medications.
Additionally, 31% adults report not taking their medicines as prescribed at some point in the past year because of the cost. This includes 21% who report they have not filled a prescription or took an over-the counter drug instead, and 12% who say they have cut pills in half or skipped a dose because of the cost. (See Figure below.)
Among those surveyed by KFF, 73% support regulations that would address drug prices, including limiting the price of prescription drugs. Among Democrats, 82% support limiting prices; among Republicans, 67% support limiting prices.
Source: KFF
Get the latest industry news, event updates, and more from Managed healthcare Executive.
PBM-Offered Genomics Testing Could Reshape Prescribing of Medications
August 1st 2025Two PBMs, True Rx Health Strategies and Capital Rx, are using pharmacogenomics — how a person’s DNA affects their response to medications — to reduce the trial-and-error of prescribing medications, saving employers and patients time and money.
Read More
FDA Extends Review of Blenrep Combinations in Multiple Myeloma
August 1st 2025Last week, an FDA advisory committee against the risk-benefit profile of Blenrep in combination with other therapies. Regulators and reviewers were concerned about the ocular side effects and dosing and tolerability. The new action date is Oct. 23, 2025.
Read More